The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma
Authors:
- 19 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 45 (7) , 885-894
Abstract
Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland cancer characterized by biphasic tubular structures composed of inner ductal and outer clear myoepithelial cells. Because of its histologic variety and overlap of histologic features with other salivary gland tumors, there are broad differential diagnoses. The HRAS Q61R mutation has been reported to be frequent in and specific to EMC. We evaluated the usefulness of RAS Q61R mutant-specific immunohistochemical (IHC) staining for detecting this genetic alteration in EMC. We investigated 83 EMC cases and 66 cases of salivary gland tumors with an EMC-like component, including pleomorphic adenoma, adenoid cystic carcinoma, basal cell adenoma/adenocarcinoma, and myoepithelial carcinoma. Sanger sequencing was performed for HRAS, KRAS, and NRAS. The diffuse and membranous/cytoplasmic RAS Q61R IHC expression was observed in 65% of EMC cases, in which all cases harbored the HRAS Q61R mutation. IHC-positive cases were present only in de novo EMCs (54/76 cases, 71%) but not in EMCs ex pleomorphic adenoma. The immunoreactivity was almost always restricted to the myoepithelial cells. Conversely, all EMC cases lacking the HRAS Q61R mutation were negative on IHC. In addition, only 3% of EMC-like tumors showed the abovementioned immunopositivity. None of the cases examined carried KRAS or NRAS mutations. IHC for RAS Q61R is highly sensitive and specific for detecting the HRAS Q61R mutation in EMC. Since significant immunopositivity was almost exclusively identified in nearly two thirds of EMCs but seldom in the histologic mimics, the IHC of RAS Q61R is a useful tool for diagnosing EMC in general pathology laboratories.Keywords
This publication has 48 references indexed in Scilit:
- Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanomaLaboratory Investigation, 2015
- HRAS Mutations in Epithelial–Myoepithelial CarcinomaHead and Neck Pathology, 2013
- “Dedifferentiation” and High-Grade Transformation in Salivary Gland CarcinomasHead and Neck Pathology, 2013
- A Double-Clear Variant of Epithelial-Myoepithelial Carcinoma of the Parotid GlandHead and Neck Pathology, 2012
- Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasmsLaboratory Investigation, 2011
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyActa Neuropathologica, 2011
- Epithelial-Myoepithelial Carcinoma With High Grade TransformationAmerican Journal of Surgical Pathology, 2010
- Sebaceous Epithelial-Myoepithelial Carcinoma of the Salivary Gland: Clinicopathologic and Immunohistochemical Analysis of 6 Cases of a New Histologic VariantAmerican Journal of Surgical Pathology, 2008
- Epithelial-Myoepithelial Carcinoma: A Review of the Clinicopathologic Spectrum and Immunophenotypic Characteristics in 61 Tumors of the Salivary Glands and Upper Aerodigestive TractAmerican Journal of Surgical Pathology, 2007
- COMPARTMENTALIZED RAS/MAPK SIGNALINGAnnual Review of Immunology, 2006